https://fusionpharma.discourse.group/t/about-the-community-forum-support-category/1 2026-03-23T11:51:47Z https://fusionpharma.discourse.group/t/about-the-agency-interactions-category/3 2026-03-23T11:51:48Z https://fusionpharma.discourse.group/t/welcome-to-fusion-pharma-limited/5 2026-07-27T10:43:12Z https://fusionpharma.discourse.group/t/about-the-lifecycle-management-category/8 2026-04-09T13:13:23Z https://fusionpharma.discourse.group/t/about-the-marketing-authorisations-strategy-category/11 2026-04-09T13:25:30Z https://fusionpharma.discourse.group/t/about-the-artificial-intelligence-in-regulatory-affairs-category/98 2026-06-30T09:16:53Z https://fusionpharma.discourse.group/t/about-the-biosimilar-applications-category/117 2026-08-25T13:59:46Z https://fusionpharma.discourse.group/t/about-the-renewals-category/118 2026-08-25T14:01:10Z https://fusionpharma.discourse.group/t/about-the-change-of-ownerships-category/119 2026-08-25T14:01:28Z https://fusionpharma.discourse.group/t/about-the-post-authorisation-commitments-category/120 2026-08-25T14:03:08Z https://fusionpharma.discourse.group/t/about-the-quality-cmc-regulatory-category/121 2026-08-25T14:07:45Z https://fusionpharma.discourse.group/t/about-the-clinical-trials-development-category/122 2026-08-25T14:08:37Z https://fusionpharma.discourse.group/t/about-the-clinical-trial-applications-category/123 2026-08-25T14:09:10Z https://fusionpharma.discourse.group/t/about-the-substantial-modifications-category/124 2026-08-25T14:09:32Z https://fusionpharma.discourse.group/t/about-the-paediatric-pips-category/125 2026-08-25T14:09:57Z https://fusionpharma.discourse.group/t/about-the-development-strategy-category/126 2026-08-25T14:10:20Z https://fusionpharma.discourse.group/t/about-the-specialist-product-areas-category/127 2026-08-25T14:10:45Z https://fusionpharma.discourse.group/t/about-the-veterinary-medicines-category/128 2026-08-25T14:11:03Z https://fusionpharma.discourse.group/t/about-the-herbal-and-homeopathic-medicines-category/129 2026-08-25T14:11:20Z https://fusionpharma.discourse.group/t/about-the-biologics-category/130 2026-08-25T14:11:35Z https://fusionpharma.discourse.group/t/about-the-atmps-category/131 2026-08-25T14:11:49Z https://fusionpharma.discourse.group/t/about-the-regulatory-intelligence-policy-category/132 2026-08-25T14:12:17Z https://fusionpharma.discourse.group/t/how-early-should-we-decide-between-a-uk-national-maa-and-another-available-route/135 2026-10-09T12:41:13Z https://fusionpharma.discourse.group/t/about-the-ai-tips-and-tricks-category/138 2026-10-13T10:14:34Z https://fusionpharma.discourse.group/t/about-the-ai-news-category/139 2026-10-13T10:14:46Z https://fusionpharma.discourse.group/t/about-the-ai-in-regulatory-affairs-category/140 2026-10-13T10:15:02Z https://fusionpharma.discourse.group/t/what-should-a-submission-readiness-review-cover-before-a-new-maa-is-filed/141 2026-10-19T12:28:02Z https://fusionpharma.discourse.group/t/when-should-we-start-preparing-a-marketing-authorisation-renewal/143 2026-10-14T14:08:41Z https://fusionpharma.discourse.group/t/does-project-orbis-replace-the-need-for-a-country-specific-regulatory-strategy/144 2026-10-14T14:11:32Z https://fusionpharma.discourse.group/t/test-post-is-this-medicine-ok-to-licence/145 2026-10-19T12:31:18Z https://fusionpharma.discourse.group/t/about-the-resources-category/146 2026-10-22T08:32:38Z https://fusionpharma.discourse.group/t/mhra-product-information-quality-unit-piqu-webinar-21-10-2026/147 2026-10-22T08:41:16Z